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Abstract 
 New compounds were synthesized by the reaction of 3-acetyl-5-
methoxy-2-methylbenzofuran (1) with cyanoacetylhydrazine which afforded 
the hydrazide hydrazone derivative 2. Compound 2 underwent a series of 
heterocyclization reactions to give the new pyrazole, isoxazole, 
cyclopentanothiophene, thiazole, triazole, 2H-chromene and pyridone 
derivatives (3-13). The elemental and spectral data (IR, 1H NMR and MS) 
characterized their structures. Screening for some selected compounds was 
carried for their potential antioxidant activities using ABTS. Among the 
tested samples compounds 9, 11, 5 and 10 exhibited promising activity. 
 
Keywords: Cyanoacetylhydrazine, benzo[b]furan, binary heterocyclic 
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Introduction  
 Benzofuran is a privileged pharmacophore widely existing in 
numerous natural products, biologically active compounds and 
pharmaceuticals (Messina et al., 2000; Yeung K. S., 2012). Accordingly, 
flurry of synthetic methods have been devoted to the development of 
synthetic approaches for benzofuran containing heterocycles (Gadaginamath 
et al., 2003). In particular, compounds bearing the benzo[b]furan structural 
framework have stimulated significant interest due to their biological 
importance (Verma et al., 2011; Deshpande et al., 2012) such as anti-
inflammatory (Yadav et al., 2014; Xiea et al., 2014) , antimicrobial (Hirosato 
et al., 2002), antifungal (Khan et al., 2005), antituberecular (Prado et al., 
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2006; Manna et al., 2010) , antihyperglycemic (Hsieh et al., 2015), 
analgesic( El-Sawy et al., 2014), antiviral (Malpania et al., 2014; Takaya et 
al., 2011; Gopalsamy et al., 2006; Rida et al., 2006), and anticancer activities 
(Parekh et al., 2011; Hranjec et al., 3013., Wang et al., 2013; Baraldi et al., 
2003; Romagnoli et al., 2009; Kamal et al., 2014). Within this context, 
benzo[b]furan-based compounds acquired considerable attention from the 
pharmaceuticals markets as they constitute the core scaffold of several 
bioactive compounds and many marketed drugs such as Galantamine (I) 
which used in treatment of mild to moderate Alzheimer’s disease, Tasimelton 
(II) which used in the treatment of non-24-h sleep-wake disorder 
(N24HSWD), Ramlteon (III) which used in the treatment of delayed sleep 
phase syndrome, Psoralen (IV) which used in the treatment for psoiasis, 
eczema, vitiligo and cutaneous T-cell lymphoma , Trioxsalen (V) which act 
as photosensitizer used to increase skin tolerance to sunlight and enhance 
pigmentation and Methoxsalen (VI) which used to treat psoriasis, eczema, 
vitiligo, cutaneous lymphomas (Reshma et al., 2015)  (Figure 1). 
 
Figure 1 
 
 It is worth noting that benzo[b]furan ring systems bearing various 
substituents at the C-3 position represent a significant source of inspiration 
for the design of structural analogues with improved medicinal profiles in 
pharmaceutical chemistry. This group of heterocycles is usually clinically 
more potent moiety and possesses diverse pharmacological properties and 
profound efficacy. Benzbromarone (VII) used in treatment of gout, 
benzofuran derivative VIII act as tubulin polymerization and growth of 
MCF-7 cell lines inhibitors(Wu et al., 2013) and benzofuran-3-
yl(phenyl)methanones IX considers an inhibitor of SIRT1 which important 
in the treatment of cancer diabetes (Flynn et a., 2002)  (figure 2). 
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Figure 2 
 
 In continuation of our previous work (Abdel-Rahman  et al., 2013; 
Berghot et al., 2014; Bondock et al., 2008; Metwally et al., 2011; El-Desoky 
et al., 1998) in the synthesis of heterocyclic compounds that are biologically 
active, we herein report the synthesis of benzo[b]furan-containing 
compounds with diverse heterocyclic functionality (e.g., oxazole, pyrazole, 
thiophene, thiazole, triazole and 2-pyridone) at C-3 position. The 
corresponding antioxidant profile of these compounds will be evaluated 
using ABTS antioxidant assay. 
 
Result and discussion 
 2-Cyano-N-[1-(5-methoxy-2-methylbenzofuran-3-
yl)ethylidene]acetohyd- razide (2) was prepared via the condensation of 3-
acetyl-5-methoxy-2-methylbenzofuran (1) (Guru et al., 2003)  with 
cyanoacetohydrazide in  ethanol containing a catalytic amount of acetic acid. 
The structure of compound 2 was confirmed based on its analytical and 
spectral data. The infrared spectrum exhibited absorption bands at 3197 
(NH), 2262 (CN) and 1683 cm-1 for (CO). The 1H NMR spectrum in DMSO-
d6 showed signals at δ (ppm): 2.34 (s,3H,CH3),2.57(s,3H,CH3),3.80 
(s,3H,OCH3) , 4.23 (s,2H,CH2) , 6.8-7.8 (m,3H,Ar-H) , 11.00 (s,1H,NH). Its 
13C-NMR spectrum showed two important signals characteristic of carbon 
atoms from C=O and CN groups at δ 165.55 and 160 ppm, respectively. The 
mass spectrum showed a molecular ion peak at m/z= 285 corresponding to 
its molecular formula C15H15N3O3. 
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 Chromene derivatives are widely used for the production of highly 
effective fluorescent pigments (Zahang et al., 2003; Christie et al., 1999). 
Some derivatives also play an important role in electro photographic and 
electroluminescent devices (Saski et al., 1994). Moreover, many other 
derivatives are well known for their significant biological and medicinal 
activities (Melagraki et al., 2009). Thus,   cyclocondensation of 2 with 
salicylaldehyde or 2-hydroxynaphthaldehyde in ethanol containing pipridine 
furnished smoothly 2-imino-N-[1-(5-methoxy-2-methylbenzofuran-3-
yl)ethylidene]-2H-chromene-3-carbohydrazide and 2-imino-N-[1-(5-
methoxy-2-methylbenzofuran-3-yl)ethylidene]-2H-benzo[g]chromene-3-
carbohydrazide (3 and 4), respectively. The analytical and spectral data of 
the products are in agreement with the proposed structure. The IR spectrum 
of 3 showed absorption bands at 3362, 3223 for (2NH) and 1681 cm-1 for 
(CO). The   1H NMR (DMSO-d6,δ, ppm) of 3 revealed signals at δ (ppm): 
2.32 (s, 3H, CH3), 2.66(s, 3H, CH3), 3.82 (s, 3H, OCH3), 6.84-7.94 (m, 7H, 
Ar-H), 8.63 (s, 1H, CH) , 9.27(s, 1H, NH) 13.56 (s, 1H, NH). The molecular 
weight of 3 was revealed by mass spectra which showed a molecular ion 
peak at m/z= 389 corresponding to the molecular formula C22H19N3O4. The 
IR spectrum of compound 4 exhibited stretching bands at 3406, 3265 for 
(2NH) and at 1675 cm-1 for (CO). The 1H NMR spectrum (DMSO-d6,δ,ppm) 
exposed signals at δ (ppm): 2.33 (s, 3H, CH3), 2.63  (s, 3H, CH3), 3.84 (s, 
3H, OCH3), 6.7-7.8 (m, 7H, Ar-H), 8.59 (s, 1H, CH),  9.16    (s, 1H, NH), 
13.51 (s, 1H, NH). The mass spectrum showed a molecular ion peak at m/z= 
439 corresponding to its molecular weight. 
 Reaction of 2 with p-anisaldehyde afforded the corresponding anisal 
derivative 2-cyano-N-[1-(5-methoxy-2-methylbenzofuran-3-yl)ethylidene)-
3-(4-methoxyphenyl]acrylohydrazide(5). The IR spectrum of 5 showed 
absorption bands at 3318 for (NH), 2212 for (CN) and at 1660 cm-1 for (CO). 
The 1H NMR spectrum lacked a singlet for methylene group at 4.23 ppm and 
revealed instead a singlet signal at 7.69 ppm for the newly formed (CH=C) 
function. The mass spectrum showed a molecular ion peak at m/z = 403 
corresponding to its molecular formula C23H21N3O4. 
 The anisal derivative 5 was utilized in the synthesis of pyrazole and 
isoxazole moieties via its reaction with the bifunctional nucleophilic 
reagents, hydrazine hydrate and hydroxyl amine hydrochloride respectively. 
Thus heating 5 with hydrazine hydrate in ethanol afforded 5-amino-N-[1-(5-
methoxy-2-methylbenzofuran-3-yl)ethylidene]-3-(4-methoxyphenyl)-1H-
pyrazole-4-carbohydrazide (6). The IR spectrum lacked the stretching 
absorption band for a cyano group with the appearance of a new broad band 
at 3470 to 3250 for both (NH) and (NH2) groups. The 
1H NMR spectrum 
lacked a singlet for methylene group protons and revealed a singlet at 12.23 
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ppm for NH proton of the pyrazole ring. The mass spectrum showed a 
molecular ion peak at m/z = 433 corresponding to its molecular weight.   
 Refluxing 5 with hydroxylamine hydrochloride in ethanol containing a catalytic amount of triethylamine yielded 5-amino-N-[1-(5-methoxy-2-methylbenzofuran-3-yl)ethylidene]-3-(4-methoxyphenyl)isoxa-              azole-4-
carbohydrazide (7). The chemical and spectral data proved its structure. 
Thus, the IR spectrum lacked absorption for a cyano group with the 
appearance of a new stretching broad band for (NH) and (NH2) groups. The 
1H NMR spectrum revealed a new singlet at 6.24 ppm for NH2 with the 
disappearance of a singlet for methylene group protons at 4.23 ppm. Mass 
spectrum showed a molecular ion peak at m/z = 434 corresponding to its 
molecular formula C23H22N4O5 (scheme 1). 
Scheme 1 
 
 Next we examined the reactivity of the methylene group present in 
compound 2 towards diazonium salts. Thus the reaction of 2 with benzene 
diazonium chloride gave the hydrazone derivative 2-[2-(1-(5-methoxy-2-
methylbenzofuran-3-yl)ethylidene)hydrazinyl]-2-oxo-N-
phenylacetohydrazonoyl cyanide (8). The analytical and spectral data of the 
product is in consistent with the proposed structure. The IR spectrum showed 
two characteristic bands at 3435 and 3242 for 2 (NH) groups, stretching band 
at 2213 for (CN) function and at 1683 cm-1 for (CO) group, while its 1H-
NMR spectrum displayed five singlet signals at 2.37 (s, 3H, CH3), 2.67 (s, 
3H, CH3), 3.8 (s, 3H, CH3), 10.52 (s, 1H, NH) and 11.98 (s, 1H, NH) and a 
multiplet signal at (6.8-7.8) ppm for the aromatic protons. In addition its 13C-
NMR spectrum which is compatible with its structure . The mass spectrum 
showed a molecular ion peak at m/z = 389 corresponding to its molecular 
weight.  
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 Refluxing the arylhydrazone 8 with hydroxylamine hydrochloride in 
ethanol and triethylamine as a base gave 1,2,3-triazole derivative 5-amino-
N'-[1-(5-methoxy-2-methylbenzofuran-3-yl)ethylidene]-2-phenyl-2H-1,2,3-
triazole-4-carbohydrazide (9) via the amidoxime intermediate (Scheme 2).  
Scheme 2 
 
 The spectral data for compound 9 proved the correct proposed 
structure. The IR spectrum showed characteristic bands at 3380 (NH), 3279 
and 3241 (NH2) and 1660 cm
-1 (CO) and lacked an absorption band for the 
cyano group. The 1H NMR spectrum lacked a singlet at 10.52 ppm for NH 
group with the appearance of a new singlet signal at 6.4 ppm for NH2 group. 
Also its mass spectrum showed a molecular ion peak at m/z = 404 
corresponding to its molecular formula C21H20N6O3. 
 Moreover, Gewald reaction of 2 with elemental sulfur and phenyl 
isothiocyanate in warming ethanol containing triethylamine as a basic 
catalyst afforded 4-amino-N'-[1-(5-methoxy-2-methylbenzofuran-3-
yl)ethylidene]-3-phenyl-2-thioxo-2,3-dihydrothiazole-5-carbohydrazide (10). 
The IR spectrum of compound 10 showed a broad signal at 3500 - 3391 for 
(NH and NH2) and the absence of the band assignable to the cyano function. 
The 1H NMR spectrum lacked a singlet at 4.23 ppm for a methylene group 
and instead revealed a new singlet signal at 7.87 ppm for NH2 group. The 
mass spectrum showed a molecular ion peak at m/z = 452 corresponding to 
its molecular weight.   
 Gewald reaction of the hydrazide hydrazone 2 with cyclopentanone 
and elemental sulfur in boiling ethanol containing a catalytic amount of 
morpholine  gave the corresponding thiophene derivative 3-amino-N-[1-(5-
methoxy-2-methylbenzofuran-3-yl)ethylidene]-5,6-dihydro-4H-
cyclopenta[b]thiophene-2-carbohydrazide (11). The IR spectrum of 
compound 11 lacked an absorption bands assignable to a cyano function 
while revealed the presence of a broad band for both NH and NH2 groups at 
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3500 to 3232 cm-1. The 1H NMR spectrum lacked a singlet for methylene 
group with the appearance of a multiplet for the cyclopentano protons in the 
aliphatic region at 2.07 to 2.9 ppm.  
 2-Pyridone derivatives are known to exhibit diverse biological 
activities (Good et al., 2016) in view of this herein the synthesis of some 2-
pyridone derivatives via the reaction of compound 2 with certain nucleophilic 
reagents. Thus, when 2 was fused with acetylacetone in the presence of a 
catalytic amount of pipridine a cyclocondensation reaction smoothly afforded 
1-[(1-(5-methoxy-2-methylbenzofuran-3-yl)ethylidene)amino]-4,6-dimethyl-
2-oxo-1,2-dihydropyridine-3-carbonitrile derivative (12). 
 The IR spectrum of compound 12 exhibited absorption bands at 2214 
for (CN) and 1658 cm-1 for (CO). The 1H NMR spectrum revealed five 
singlet signals for five methyl groups besides a singlet at 6.47 ppm for an 
olefinic proton and lacked absorption band for (NH). The mass spectrum 
showed a molecular ion peak at m/z = 349 represents its molecular weight. 
 In addition we studied the reactivity of the hydrazide hydrazone 
derivative 2 towards cinnamonitrile. Thus the reaction of 2 with 2-
benzylidene malononitrile give the pyridine derivative 6-amino-1-[(1-(5-
methoxy-2-methylbenzofuran-3-yl)ethylidene)amino]-2-oxo-4-phenyl-1,2-
dihydropyridine-3,5-dicarbonitrile (13). 
 The analytical and spectral data supported the structure of compound 
13. The IR spectrum showed absorption bands at 3404 and 3305 cm-1 for 
(NH2) group. The 
1H NMR spectrum lacked two singlet signals for 
methylene group protons and (NH) with the appearance of new singlet at 
8.26 ppm for (NH2) group. The mass spectrum showed a molecular ion peak 
at m/z = 437 corresponding to its molecular formula C25H19N5O3 (scheme 3). 
  
Scheme 3 
European Scientific Journal October 2017 edition Vol.13, No.30 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
304 
 The antioxidant activity of the synthesized compounds was evaluated 
employing the 2,2'-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) 
(ABTS). Regarding the structure activity relationship (SAR) most of the 
synthesized compounds showed a good antioxidant activity compared to 
Vitamin C. Within this context, compounds 9, 11, 5 and 10 showed 87, 84, 
83 and 80 % inhibition, respectively. The higher antioxidant of these 
compounds can be suggested as it depends on the role of antioxidant to 
remove free radicals. One important mechanism through which this is 
achieved is by donating hydrogen to free radicals which removes the odd 
electron feature which is responsible for radical reactivity. So, in these 
compounds depends on the presence of the amino hydrogen atoms, whereas 
this atom was under the influence resonance effect among the heterocyclic 
rings. The tautomer’s play an important role in releasing of hydrogen. 
 According to these suggestions, the rest of the compounds exhibited 
moderate activity. Fortunately, there was a correlation between the 
compounds structures and the activity, suggesting that it is not a general 
benzofuran activity. The trizol-, pyrazol-, isoxazol-, thiophen- based 
benzofurans were among the most active compounds in this assay which can 
be stabilize an unpaired electron in general which enhance the antioxidant 
efficiency of the molecules. Surprisingly, compounds 4 and 12 with pyan 
and pyridone functionality were the least active in this assay.  
Table(1): antioxidant activity of compounds 2-13 by ABTS method  
ABTS 
 Abs(control)-Abs(test)/Abs(control)X100 Method 
% inhibition Absorbance of samples Compounds 
76.1% 0.122 2 
76.5% 0.082 3 
61.6% 0.196 4 
83.9% 0.120 5 
67.0% 0.062 6 
71.4% 0.077 7 
70.4% 0.151  8  
87.8% 0.168 9 
80.4% 0.192 10 
84.9% 0.100 11 
62.3% 0.146 12 
74.9% 0.128 13 
0% 0.510 Control of ABTS 
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89.0% 0.056 Ascorbic-acid 
 
 
 
Experimental 
 All melting points (uncorrected) are in degree centigrade and were 
determined on Gallenkamp electric melting point apparatus. Elemental 
analyses were carried out in the Micro analytical Unit of the Faculty of 
Science, Cairo University. IR spectra were recorded (KBr) with a Thermo 
Scientific™ Nicolet™ iS™10 FT-IR Faculty of Science, Mansoura 
University.   NMR spectra were measured in (DMSO-d6 and CDCl3) as 
solvents at 300MHz (1HNMR) on a Bruker NMR spectrometer using TMS 
as internal standard and chemical shifts are expressed as /ppm were carried 
out in Cairo and Al-Azhar Universities. The mass spectra (EI) were recorded 
on 70 eV with Kratos MS equipment and/or Varian MAT311ASpectrometer. 
3-Acetyl-5-methoxy-2-methylbenzofuran was synthesized according to the 
previously reported procedures. 
 
2-Cyano-N-[1-(5-methoxy-2-methylbenzofuran-3-yl)ethylidene]acetoh- 
ydrazide (2) 
 To a solution of 5-methoxybenzofuran derivative 1 (1mmol) in 
ethanol containing a catalytic amount of acetic acid an equimolar amount of 
cyanoacetohydrazide was added, the reaction mixture was heated under 
reflux for 8 h, cooled to room temperature. The solid formed was filtered off, 
collected and recrystallized from ethanol to give compound 2. 
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 White crystals; yield (86%); m.p. 188-90◦C; IR (KBr): ѵ/cm−1 = 3197 
(NH), 2262 (CN), 1683 cm-1(CO). 1H NMR (DMSO-d6) δ (ppm): 2.34 (s, 
3H, CH3), 2.57 (s, 3H, CH3), 3.8 (s, 3H, OCH3), 4.23 (s, 2H, CH2), 6.8-7.8 
(m, 3H, Ar-H), 11.00 (s, 1H, NH); 13C-NMR (DMSO-d6, δ ppm): 165.55, 
156.38, 155.78, 147.71, 127.07, 116.08, 115.52, 112.4, 111.11, 105.84, 
103.9, 55.45, 25.09, 16.89, 14.63 ; MS (EI, 70 eV): m/z (%) = 285.98 (M+ 
2.02), 242.98(17.12), 218(21.37), 200(100), 185.97(37.68), 159.97(73.23), 
111(44.47).  
Anal. for C15H15N3O3 (285.5):  
 Calcd: C, 63.15;         H, 5.30;        N, 14.73 %. 
 Found: C, 63.16;        H, 5.29;        N, 14.72 %. 
 
Preparation of compounds 3 and 4  
 salicylaldehyde (1 mmol) or 2-hydroxynaphthaldehyde (1mmol)  was 
added to a solution of compound 1 (1 mmol) in ethanol (25 mL) containing 
few drops of piperidine and the mixture was heated under reflux for 2 h. The 
solid products formed was collected by filtration, dried, and recrystallized 
from DMF/ethanol mixture to afford compound 3, 4. 
 
2-Imino-N-(1-(5-methoxy-2-methylbenzofuran-3-yl)ethylidene)-2H-
chromene-3carbohydrazide (3) 
 Yellow crystals; yield (83%); mp 218-20˚C; IR (KBr): υ/cm-1= 3362, 
3223 for 2 (NH) and 1681 cm-1 for (CO). 1H NMR (400 MHz, DMSO-d6): 
/ppm= 2.32     (s, 3H, CH3), 2.66 (s, 3H, CH3), 3.82 (s, 3H, OCH3), 6.8-7.9 
(m, 7H, Ar-H), 8.63 (s, 1H, CH), 9.27 (s, 1H, NH), 13.56 (s, 1H, NH); MS 
m/z (%): 389 (M+, 4.2), 217.99 (19.37), 171.96 (100), 144.99 (68.47), 118 
(67.26), 89.02 (22). 
Anal. for C22H19N3O4 (389.96):  
Calcd : C, 67.86;      H, 4.92;       N, 10.79 %.  
Found: C, 67.85;      H, 4.93;       N, 10.81 %. 
 
2-Imino-N-[1-(5-methoxy-2-methylbenzofuran-3-yl)ethylidene]-2H-
benzo[g]chromene-3-carbohydrazide (4) 
 Yellow crystals; yield (79%); m.p 236-238˚C; IR (KBr): υ/cm-1= 
3406,3265 for 2 (NH), 1675 (CO). 1H NMR (400 MHz, DMSO-d6):  
(ppm)= 2.33 (s, 3H, CH3), 2.63   (s, 3H, CH3), 3.84 (s, 3H, OCH3), 6.7-7.8 
(m, 7H, Ar-H), 8.59 (s, 1H, CH), 9.16 (s, 1H, NH), 13.51 (s, 1H, NH); MS 
m/z (%): 439.07 (M+, 1.18), 388.97 (84.29), 276.96 (47.96), 171.97 (100), 
105 (41.45).  
Anal. for C26H21N3O4 (439.07):  
Calcd:  C, 71.06;      H, 4.82;     N, 9.56 %.  
Found: C, 71.04;      H, 4.86;     N, 9.51 %. 
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2-Cyano-N-[1-(5-methoxy-2-methylbenzofuran-3-yl)ethylidene)-3-(4-
methoxyphenyl]acrylohydrazide (5) 
 A mixture of 3 (1mmol), P-anisaldehyde (1 mmol) in ethanol (30 
mL) and a few drops of piperidine was refluxed for 3 h. The solid product 
was collected by filtration and recrystallized from ethanol afforded 5. 
 Yellow sheets; yield (74%); m.p. 98-100◦C; IR(KBr): ѵ/cm−1 = 3318 
(NH), 2212 (CN), 1660 (CO); 1H NMR (DMSO-d6) δ (ppm): 2.38 (s, 3H, 
CH3), 2.66           (s, 3H, CH3), 3.8 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 6.8-
7.4 (m, 7H, Ar-H), 7.69 (s, 1H, =CH) , 11.1 (s, 1H, NH); MS (EI, 70 eV): 
m/z (%) = 403 (M+, 87.95), 389(32), 336(100), 285(28.36), 218(98.23), 
203(95.97).  
Anal.for C23H21N3O4 (403.44):  
Calcd:  C, 68.47;     H, 5.25;     N, 10.42 %.  
Found: C, 68.45;     H, 5.23;     N, 10.44 %. 
 
3-Amino-N-[1-(5-methoxy-2-methylbenzofuran-3-yl)ethylidene)-5-(4-
methoxyphenyl]-1H-pyra- zole-4-carbohydrazide (6) 
 To a solution of  5 (1mmol) in ethanol (30 ml) an equimolar amount 
of hydrazine monohydrate was added, the mixture was heated under reflux 
for 2 h, the solution concentrated to 5 ml. the formed product was collected 
by filtration and recrystallized from ethanol to give compound 6. 
 Yellow crystal; yield (61%); m.p. 278-81◦C; IR(KBr): ѵ/cm−1 = 
3470 - 3250 2 (NH) and (NH2)  and 1660 (CO); 
1H NMR (DMSO-d6) δ 
(ppm): 2.32 (s, 3H, CH3), 2.67 (s, 3H, CH3), 3.85 (s, 3H, OCH3), 3.87 (s, 3H, 
OCH3), 6.83-7.65 (m, 7H, Ar-H) , 7.32 (s, 2H, NH2), 11.6 (s, 1H, NH), 12.23 
(s, 1H, NH); MS (EI, 70 eV): m/z (%) = 433 (M-1 1.02), 326.1(41.5), 
269.2(36), 218(91), 203.9(62.8).  
Anal. For C23H23N5O4 (433.47):  
Calcd:  C, 63.73;     H, 5.35;     N, 16.16 %.  
Found: C, 63.71;     H, 5.32;     N, 16.13 %. 
 
5-amino-N-[1-(5-methoxy-2-methylbenzofuran-3-yl)ethylidene)-3-(4-
methoxyphenyl]isoxazole-4-carbohydrazide (7) 
 To a solution of 5 (1mmol) in ethanol (30 ml) an equimolar amount 
of hydroxylamine hydrochloride was added, the mixture was heated under 
reflux for 4 h, the solution concentrated to 5 ml. the formed product was 
collected by filtration and recrystallized from ethanol to give compound 7. 
 Yellow crystal; yield (73%); m.p. 262-5◦C; IR(KBr): ѵ/cm−1 = 3421 
- 3265 for (NH) and (NH2) and 1661 (CO); 
1H NMR (DMSO-d6) δ (ppm): 
2.33 (s, 3H, CH3), 2.61 (s, 3H, CH3), 3.85 (s, 3H, OCH3), 3.88 (s, 3H, 
OCH3), 6.24 (s, 2H, NH2), 6.7-7.6 (m, 7H, Ar-H), 11.92 (s, 1H, NH); MS 
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(EI, 70 eV): m/z (%) = 434.2 (M+ 10.24), 403.2(32.5), 327.1(36), 
244.2(29.8), 218(91.2), 203.4(42.3).  
Anal. for C23H22N4O5 (434.45):  
Calcd:  C, 63.59;     H, 5.10;      N, 12.90 %.  
Found: C, 63.61;     H, 5.08;      N, 12.88 %. 
 
2-[2-(1-(5-Methoxy-2-methylbenzofuran-3-yl)ethylidene)hydrazinyl]-2-
oxo-N-phenylacetohydrazonoyl cyanide (8) 
 A cold suspension of benzene diazonium salt (1mmol) (prepared 
from 1mmol of aniline with the appropriate quantities of sodium nitrite and 
hydrochloric acid) was gradually added to a cold solution (0–5◦C) of 
compound 1 (1mmol) in pyridine (10mL) with continuous stirring for 1 h. 
The reaction mixture was poured on crushed ice containing hydrochloric 
acid. The product obtained was filtered off, washed with water and 
recrystallized from dilute ethanol to give compound 8.  
 Yellow crystals; yield (70%); m.p. 229-32◦C; IR (KBr): ѵ/cm−1 = 
3435, 3242 2 (NH), 2213 (CN), 1683 (CO). 1H NMR (DMSO-d6) δ (ppm): 
2.37 (s, 3H, CH3), 2.67 (s, 3H, CH3), 3.80 (s, 3H, OCH3), 6.8-7.8 (m, 8H, 
Ar-H), 10.52 (s, 1H, NH), 11.98 (s, 1H, NH); 13C-NMR (DMSO-d6, δ ppm): 
155.27, 153.36, 148.79, ArC 137.19-102.31 ; MS (EI, 70 eV): m/z (%) = 
389.98 (M+ 3.08), 218.02(100), 203.02(48), 187(19.64), 92.01(23.78), 
77.01(38.05).  
Anal. for C21H19N5O3 (389.98):  
Calcd. C, 64.77;       H, 4.92;       N, 17.98 %.  
Found: C, 64.75;      H, 4.91;       N, 17.99 %. 
 
5-Amino-N-[1-(5-methoxy-2-methylbenzofuran-3-yl)ethylidene]-2-
phenyl-2H-1,2,3-triazole-4-carbohydrazide (9) 
 A mixture of compound 8 (1mmol) and hydroxylamine hydrochloride 
(1mmol) in the presence of drops of triethylamine was refluxed in ethanol 
(10ml) for 4 h. The solid precipitate so formed was filtered off and 
recrystallized from Ethanol as a solvent to give compound 9. 
 Brown powder; yield (72%); m.p. 112-4◦C; IR (KBr): ѵ/cm−1 = 3380 
(NH), 3279, 3241 (NH2), 1660 (C=O). 1H NMR (DMSO-d6) δ (ppm): 2.32 
(s, 3H, CH3), 2.68 (s, 3H, CH3), 3.84 (s, 3H, OCH3), 6.4 (s, 2H, NH2), 6.8-
7.9 (m, 8H, Ar-H), 11.8 (s, 1H, NH); MS (EI, 70 eV): m/z (%) = 404 (M+ 
4.52), 279 (12), 219 (32.5), 203 (100), 149 (38.65).  
Anal. for C21H20N6O3 (404.43):  
Calcd:  C, 62.37;      H, 4.98;      N, 20.78 %. 
Found: C, 62.35;      H, 4.93;      N, 20.75 %. 
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2-Amino-N-[1-(5-methoxy-2-methylbenzofuran-3-yl)ethylidene]-5,6-
dihydro-4H-cyclopenta[b]thiophene-3-carbohydrazide (10) 
 To a solution of compound 3 (2 mmol) in absolute ethanol (20 mL) 
containing trimethylamine (5 drops), elemental sulfur (2 mmol) and 
phenylisothiocyanate (2 mmol) were added. The reaction mixture was heated 
at 60°C for 2 h with continuous stirring then poured onto beaker containing 
an ice/water mixture containing few drops of hydrochloric acid. The formed 
solid product was collected by filtration, dried well, and recrystallized from 
ethanol to give compound 10.  
 Yellow crystal; yield (70%); m.p. 214-6◦C; IR(KBr): ѵ/cm−1 = 3500-
3391 (NH) and (NH2), 1681 (CO); 
1H NMR (DMSO-d6) δ (ppm): 2.33 (s, 
3H, CH3), 2.72 (s, 3H, CH3), 3.80 (s, 3H, OCH3), 6.8-7.6 (m, 8H, Ar-H), 
7.87 (s, 2H, NH2), 10.99 (s, 1H, NH);
 13C-NMR (DMSO-d6, δ ppm):165.55, 
163.22, 155.74, 154.7, 147.87, 134.87, 130.11, 128.94, 127.3, 116.16, 
112.55, 111.32, 103.91, 103.39, 80.133, 55.55, 30.71, 17.4, 14.0;  MS (EI, 70 
eV): m/z (%) = 452 (M+ 8.62), 285(88.15), 243(44.23), 218(100), 
203(84.12), 187(39.78). 
Anal. for C22H20N4O3S2 (452.55): 
Calcd:  C, 58.39;      H, 4.45;     N, 12.38;     S, 14.17 %. 
Found: C, 58.42;      H, 4.46;     N, 12.33;     S, 14.14 %. 
 
3-Amino-N-[1-(5-methoxy-2-methylbenzofuran-3-yl)ethylidene]-5,6-
dihydro-4H-cyclopenta[b]thiophene-2-carbohydrazide (11) 
 To a solution of compound 3 (2mmol) in ethanol (20mL) containing 
morpholine (0.5mL), elemental sulfur (2mmol) and cyclopentanone (2mmol) 
were added. The reaction mixture was heated at 60°C for 2 h with 
continuous stirring, then poured onto beaker containing an ice/water mixture 
containing few drops of hydrochloric acid. The formed solid product was 
collected by filtration, dried well, and recrystallized from ethanol to give 
compound 11. 
 Brown powder; yield (75%); m.p. 267-8 ◦C; IR(KBr): ѵ/cm−1 = 3500 
to 3232 for (NH) and (NH2) groups and 1640 (CO); 
1H NMR (DMSO-d6) δ 
(ppm): 2.07       (t, 2H, CH2), 2.17 (t, 2H, CH2), 2.36 (s, 3H, CH3), 2.7 (m, 
2H, CH2), 2.73 (s, 3H, CH3), 3.80 (s, 3H, OCH3), 6.8-7.4 (m, 3H, Ar-H), 
7.69 (s, 2H, NH2), 11.23 (s, 1H, NH); 
 MS (EI, 70 eV): m/z (%) = 383 (M+ 
10.42), 275(74.32), 247(55.87), 218(100), 203(89.12), 187(39.78).  
Anal. for C20H21N3O3S (383.47):  
Calcd:  C, 62.64;     H, 5.52;     N, 10.96;     S, 8.36 %.  
Found: C, 62.63;     H, 5.55;     N, 10.99;     S, 8.32 %. 
 
1-[(1-(5-Methoxy-2-methylbenzofuran-3-yl)ethylidene)amino]-4,6-
dimethyl-2-oxo-1,2-dihydropyridine-3-carbonitrile (12) 
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 A mixture of compound 1 (1mmol) and acetyl acetone (1.2mmol) in 
ethanol (15mL) containing few drops of piperidine was fused for 2 h in an oil 
bath at 150˚ C. The reaction mixture was cooled and the solid so obtained 
was filtered off and purified using TLC technique using (ethyl acetate: 
petroleum ether) as an eluent to give compound 12.  
 Yellow crystal; yield (70%); m.p. 193-5◦C; IR(KBr): ѵ/cm−1 = 2214 
(CN), 1658 cm-1 (CO); 1H NMR (DMSO-d6) δ (ppm): 2.21 (s, 3H, CH3), 
2.33 (s, 3H, CH3), 2.39 (s, 3H, CH3), 2.74 (s, 3H, CH3), 3.78 (s, 3H, OCH3), 
6.47 (s, 1H, CH), 6.9-7.5 (m, 3H, Ar-H); 13C-NMR (DMSO-d6, δ ppm): 
154.1, 149.4, 146.7,  137.7,  130.2,  122.4,  118.5,  115.4,  112.2,  110.2,  
104.6 , 92.1,  55.8,  21.2 , 20.8,  19.9;  MS (EI, 70 eV): m/z (%) = 349.98 
(M+ 4.55), 333.97(19.27), 201.01(100), 159.98(75.72), 131.98(31.57), 
89.02(17.33).  
Anal. for C20H19N3O3 (349.98):  
Calcd:  C, 68.75;      H, 5.48;      N, 12.03 %.  
Found: C, 68.72;      H, 5.45;      N, 12.08 %. 
 
4-Amino-5-benzylidene-6-imino-1-[(1-(5-methoxy-2-methylbenzofuran-
3-yl)ethylidene)amino]-2-oxo-1,2,5,6-tetrahydropyridine-3-carbonitrile 
(13) 
 An equimolar amount of compound 1 (1 mmol) and few drops of 
triethylamine were added to a solution of the arylidenemalononitrile (1 
mmol) in ethanol (20 mL). The mixture was refluxed for 2 h, then left to cool 
to room temperature. The solid product that formed was collected by 
filtration then recrystallized from ethanol to give the corresponding pyridin-
2-one derivative 13. 
 Yellow crystal; yield (64%); m.p. 230-2◦C; IR(KBr): ѵ/cm−1 = 3404, 
3305 (NH2), 2216, 2191 for 2 (CN) and 1674 (CO); 
1H NMR (DMSO-d6) δ 
(ppm): 2.3                      (s, 3H, CH3), 2.6 (s, 3H, CH3), 2.73 (s, 3H, CH3), 
2.76 (s, 3H, CH3),                              3.81 (s, 3H, OCH3), 6.94-7.57 (m, 3H, 
Ar-H), 8.26 (s, 2H, NH2); MS : m/z (%) = 437 (M
+ 48), 388 (55.47), 248 
(2.99), 218 (62.77), 187 (100), 91(45.31). 
Anal. for C25H19N5O3 (437.47):  
Calcd:  C, 68.64;     H, 4.38;      N, 16.01 %.  
Found: C, 68.61;     H, 4.41;      N, 15.96 %. 
 
Conclusion 
 In summary, we have reported the synthesis of a series of new 
benzo[b]furan derivatives linked to different types of heterocyclic rings as 
pyridine, trizol-, pyrazol, isoxazol, thiophen, chromene and pyridone. The 
newly synthesized compounds were characterized by their elemental and 
spectral data (IR, 1H NMR and MS). Screening for some selected 
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compounds was carried for their potential antioxidant activities using ABTS. 
Compounds 9, 11, 5 and 10 showed the higher inhibition. compounds 4 and 
12 with were the least active. 
 
References: 
1. Abdel-Rahman A. H., Kandeel E. M., Berghot M. A., Abedel-Motaal 
M. (2013) J Heterocyclic Chem. 50, 298. 
2. Baraldi P. G., Romagnoli R., Bianchib N., Gambarib R. (2003) Med. 
Chem. 11, 2381. 
3. Berghot M. A., Kandeel E. M., Abdel-Rahaman A. H., Abdel-Motaal 
M. (2014) Med chem. 4(3), 381. 
4. Bondock S., El-Azap H., Kandeel E. M., Metwally M. A. (2008) 
Monatsh Chem. Christie R. M., Chih-Hung L.  (1999) Dyes Pigm. 
42, 85.  
5. Deshpande R., Bhagawan Raju M., Parameshwar S., Shanth Kumar 
S.M., Appalaraju S. and Yelagatti  M. S. (2012) Am. J. Chem. 2, 115. 
6. El-Desoky S. I., Kandeel E. M., Abdel-Rahamn A. H., Schmidt R. R.  
(1998) Z.Naturforsch. 53b, 1216. 
7. El-Sawy E. R. , Ebaid M. S. , Abo-Salema H. M. , Al-Sehemib A. G. 
, Mandoura A. H. , Shin D. S. (2014)Tetrahedron Lett. 55, 2796. 
8. Flynn B. L., Hamel E., Jung M. K. (2002) J. Med. Chem. 45, 2670. 
9. Gadaginamath G. S., Kavali R. R. and Pujar S. R. (2003) Synth 
Commun. 33(13), 2285. 
10. Good J. A.,  Silver J., Núñez-Otero C., Bahnan W., Krishnan K. S., 
Salin O., Engström P., Svensson R., Artursson P., Gylfe A., 
Bergström S., Almqvist F. (2016) J. Med. Chem. 59(5), 2094. 
11. Gopalsamy A., Aplasca A., Ciszewski G., Park K., Ellingboe J. W., 
Orlowski M., Feld B., Howe A. Y. M. (2006) Bioorg. Med. Chem. 
Lett. 16, 457. 
12. Guru S. G., Rajesh R. K., Shashikanth R. P. (2003) Synth Commun. 
33(13), 2285. Zahang Y. Y., Meng X. M., Wang X. L., Xu L. X. 
(2003) Dyes Pigm. 56, 189. 
13. Hirosato E., Miyako M., Pingli L., Ken-ichi K., Morikami K., Sogabe 
S., Hayase M., Fujii T., Sakata K., Shindoh H., Shiratori Y., Aoki Y., 
Ohtsukaa T., Nobuo Shimma (2002) Bioorg. Med. Chem. Lett. 12, 
607. 
14. Hranjec M., Sovic I., Ratkaj I., Pavlovic G., sallic N., Valjalo L., 
Pavelic K.,    Pavelic S. K., Karminski-Zamola G.  (2013) Eur. J. 
Med. Chem. 59, 111. 
15. Hsieh J. F., Lin W. J., Huang K. F., Liao J.H., Don M. J., Shen C. C., 
Shiao Y. J., Li W. T. (2015) Eur. J. Med. Chem. 26(93), 443.  
European Scientific Journal October 2017 edition Vol.13, No.30 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
312 
16. Kamal A., Reddy N. V. S., Nayak V. L., Reddy V. S., Prasad B., 
Nimbarte V. D., Srinivasulu V., Vishnuvardhan M. V. P. S., Reddy 
C. S. (2014) Chem Med Chem. 9, 117. 
17. Khan I. A., Kulkarni M. V., Gopal M., Shahabuddin M. S., Sun C.-
M. (2005) Bioorg. Med. Chem. Lett. 15, 3584. 
18. Malpania Y., Acharya R., Kim S. Y., Jeong H. C., Kim P., Han S. B., 
Kim M., Lee C. K., Kim J. N., Jung Y.-S. Eur. (2013) J. Med. Chem. 
62, 534. 
19. Manna K., Agrawal Y. K., Design (2010) Eur. J. Med. Chem. 45, 
3831. 
20. Melagraki G., Afantitis A., Igglessi-Markopoulou O., Desti A., 
Koufaki M., Kontogiorgis C., Hadjipavlou-Litina D. (2009) Eur. J. 
Med. Chem. 44, 3020.   
21. Messina, F. and Botta M. (2000) Tetrahedron Asym. 11, 4895. 
22. Metwally M. A., Bondock S., El-Azap H., Kandeel E. M. (2011) J 
Sulphur Chem. 32(5), 489. 
23. Parekh S., Bhavsar D., Savant M., Thakrar S., Bavishi A., Parmar M., 
Vala H., Radadiya A., Pandya N., Serly J., Molnar J., Shah A. (2011) 
Eur. J. Med. Chem. 46, 1942. 
24. Prado S., Ledeit H., Michel S., Koch M., Darbord J. C., Cole S. T., 
Tillequin F., Brodin P. (2006)  Bioorg. Med. Chem. 14, 5423. 
25. Rida S. M., EI-Hawash S. A. M., Fahmy H. T. Y., Hazzaa A. A., EI-
Meligy M. M. M.  Arch. Pharm. (2006) Res. 29, 826. 
26. Reshma J. N., Santosh N. D., Satish N. D.  (2015) Eur. J. Med. 
Chem. 97, 561. 
27. Wu J., Li Y., Chen K., Jiang H., Xu  M.-H., Liu  D. (2013) Eur. J. 
Med. Chem. 60, 441. 
28. Romagnoli, R. Baraldi, P. G. Carrion, Cara M. D. C. L., Cruz-Lopez 
O., Tolomeo M., Grimaudo S., Di Cristina  A., Pipitone M. R., 
Balzarini J., Zonta N., Brancale A., Hamel E., (2009) Design, Med. 
Chem. 17, 6862. 
29. Saski K., Koki K.  (1994) 23, 190; chem. Abst. 1994, 120:310929a. 
30. Takaya D., Yamashita A., Kamijo K., Gomi J., Ito M., Maekawa S., 
Enomoto N., Sakamoto N., Watanabe Y., Arai R., Umeyama H., 
Honma T., Matsumoto T., Yokoyama S. (2011)Bioorg. Med. Chem. 
19, 6892. 
31. Verma A., Pandeya S. N. and Sinha S. (2011) Int. J. Res. Ayurveda 
Pharm. 2, 1110. 
32. Wang X. -Q., Liu L. -X., Li Y., Sun C. -J., Chen W., Li L., Zhang H. 
-B., Yang  X.-D.  (2013) Eur. J. Med. Chem. 62, 111. 
33. Xiea Y. S., Kumar D., Bodduri V. D. V., Tarani P. S., Zhao B. X., 
Miao J. Y., Jang K., Shin D. -S. (2014)Tetrahedron Lett. 55, 2796. 
European Scientific Journal October 2017 edition Vol.13, No.30 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
313 
34. Yadav P., Singh P., Tewari A. K. (2014) Bioorg. Med. Chem. Lett. 
24, 2251. 
35. Yeung, K. S. (2012) Heterocycl. Chem. 29, 47.  
 
 
 
 
 
 
 
  
